Effect of supplementation of smoking men with plain or slow release ascorbic acid on lipoprotein oxidation

European Journal of Clinical Nutrition

Volumn 51, Issue 3, 1997, Pages 154-163

  Nyyssonen K ^a   Poulsen, H E ^b   Hayn, M ^c   Agerbo, P ^d   Porkkala Sarataho, E ^a   Kaikkonen, J ^a   Salonen, R ^a   Salonen, J T ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b University of Copenhagen   (Denmark)

^c UNIVERSITY OF GRAZ   (Austria)

^d Ferrosan AS   (Denmark)

Author keywords

Ascorbic acid; Lipid hydroperoxides; Lipoprotein oxidation; Pharmacokinetics; Vitamin C

Indexed keywords

ASCORBIC ACID; COPPER; HEMIN; HYDROGEN PEROXIDE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PLACEBO; VERY LOW DENSITY LIPOPROTEIN;

ABSORPTION; ADULT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; HUMAN EXPERIMENT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; OXIDATION; SLOW RELEASE FORMULATION; SMOKING;

EID: 1842404769     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600376     Document Type: Article

References (47)

1. Baker M, Cerniglia GJ & Zaman A (1990): Microtiter plate assay for the measurement of glutathione disulfide in large numbers of biological samples. Anal. Biochem. 190, 360-365.
2. Bittolo Bon G, Cazzolato G & Avogaro P (1995). In: Bellomo G, Finardi G, Maggi E & Rice-Evans C (eds). Free Radicals, Lipoprotein Oxidation and Atherosclerosis: Biological and Clinical Aspects. pp 205-228. Richelieu Press: London.
3. Bowry VW, Mohr D, Cleary J & Stocker R (1995): Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J. Biol. Chem. 270, 5756-5763.
4. Cazzolato GP, Avogaro P & Bittolo Bon G (1991): Characterization of a more electronegatively charged LDL subfraction by ion exchange HPLC. Free Rad. Biol. Med. 11, 247-253.
5. Chen C & Loo G (1995): Cigarette smoke extract inhibits oxidative modification of low density lipoprotein. Atherosclerosis. 112, 177-185.
6. Esterbauer H, Gebicki J, Puhl H & Jürgens G (1992): The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad. Biol. Med. 13, 341-390.
7. Esterbauer H, Striegl G, Puhl H & Rotheneder M (1989): Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad. Res. Comms. 6, 67-75.
8. 2+/dextran sulfate in its enzymatic measurement. Clin. Chem. 26, 931-933.
9. Frei B (1991): Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J. Clin. Nutr. 54, 1113S-1118S.
10. Frei B, England L & Ames BN (1989): Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. 86, 6377-6381.
11. Frei B, Stocker R, England L & Ames BN (1990): Ascorbate: the most effective antioxidant in human blood plasma. Adv. Exp. Med. Biol. 264, 155-163.
12. Fuller JF, Grundy SM, Norkus EP & Jialal I (1996): Effect of ascorbate supplementation on low density lipoprotein oxidation in smokers. Atherosclerosis. 119, 139-150.
13. Gibaldi M & Perrier D (1982): Pharmacokinetics. Marcel Dekker Inc: New York.
14. Harats D, Ben-Naim M, Dabach Y, Hollander G, Havivi E, Stein O & Stein Y (1990): Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis. 85, 47-54.
15. Herbert V, Shaw S, Jayatilleke E & Stopler-Kasdan T (1994): Most free-radical injury is iron-related: It is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem. Cells. 12, 289-303.
16. Jialal I & Grundy SM (1991): Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J. Clin. Invest. 87, 597-601.
17. Kagan VE, Serbinova EA, Forte T, Seita G & Packer L (1992): Recycling of vitamin E in human low density lipoproteins. J. Lipid. Res. 33, 385-397.
18. Knight JA, Pieper RK & McClellan L (1988): Specificity of the thiobarbituric acid raction: its use in studies of lipid peroxidation. Clin. Chem. 34, 2433-2438.
19. Lang JK, Kishorchandra G & Packer L (1986): Simultaneous determination of tocopherols, ubiquinols and ubiquinones in blood, plasma, tissue homogenates and subcellular fractions. Anal. Biochem. 157, 106-116.
20. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J & Cantilena LR (1996): Vitamin C pharmacokinetics in healthy volunteers: Evidence for a recommended dietary allowance. Proc. Natl. Acad. Sci. 93, 3704-3709.
21. Meydani M, Natiello F, Goldin B, Free N, Woods M, Schaefer E, Blumberg JB & Gorbach SL (1991): Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women. J. Nutr. 121, 484-491.
22. Mezzetti A, Lapenna D, Pierdomenico SD, Calafiore AM, Costantini F, Riario-Sforza G, Imbastaro T, Neri M & Cuccurullo F (1995): Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and non-smokers. Artherosclerosis. 112, 91-99.
23. Niki E (1991): Action of ascorbic acid as a scavenger of active and stable oxygen radicals. Am. J. Clin. Nutr. 54, 1119S-1124S.
24. Nyyssönen K, Kaikkonen J & Salonen JT (1997): Characterization and determinants of an electronegatively charged low-density lipoprotein in human plasma. Scand. J. Clin. Lab. Invest. (in press).
25. Nyyssönen K, Pikkarainen S, Parviainen MT, Heinonen K & Mononen I (1988): Quantitative estimation of ascorbic acid and dehydroascorbic acid by high-performance liquid chromatography - application to human milk, plasma and leukocytes. J. Liq. Chromatogr. 11, 1717-1728.
26. Nyyssönen K, Porkkala E, Salonen R, Korpela H & Salonen JT (1994): Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled trial. Eur. J. Clin. Nutr. 48, 633-642.
27. Porkkala-Sarataho E, Nyyssönen K & Salonen JT (1996): Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men. Artherosclerosis. 124, 83-94.
28. Rabl H, Khoschsorur G, Colombo T, Tatzber F & Esterbauer H (1992): Human plasma lipid peroxide levels show a strong transient increase after successful revascularization operations. Free Rad. Biol. Med. 13, 281-288.
29. Reaven PD, Khow A, Beltz W, Parthasarathy S & Witztrum JL (1993): Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by β-carotene. Arterioscler. Thromb. 13, 590-600.
30. Retsky KL, Freeman MW & Frei B (1993): Ascorbic acid oxidation product(s) protect human low density lipoprotein against atherogenic modification. J. Biol. Chem. 268, 1304-1309.
31. Retsky KL & Frei B (1995): Vitamin C prevents metal ion-dependent initiation and propagation of lipid peroxidation in human low-density lipoprotein. Biochim. Biophys. Acta. 1257, 279-287.
32. Rifici VA & Khachadurian AK (1993): Dietary supplementation with vitamins C and E inhibits in vitro oxidation of lipoproteins. J. Am. Coll. Nutr. 12, 631-637.
33. Salonen JT (1993): The role of iron as a cardiovascular risk factor. Curr. Opin. Lipidol. 4, 277-282.
34. Salonen JT (1995). In: Bellomo G, Finardi G, Maggi E & Rice-Evans C (eds). Free Radicals, Lipoprotein Oxidation and Atherosclerosis. Biological and Clinical Aspects. pp 27-52. Richelieu Press: London.
35. Salonen JT, Nyyssönen K, Tuomainen T-P, Mäenpää PH, Korpela H, Kaplan GA, Lynch J, Helmrich SP & Salonen R (1995): Increased risk of non-insulin dependent diabetes mellitus at low plasma vitamin E concentrations: a four year follow up study in men. BMJ. 311, 1124-1127.
36. Salonen JT, Nyyssönen K & Parviainen MT (1997). In: Packer L & Fuchs J (eds). Vitamin C in Health and Disease. Marcel Dekker: New York. (in press).
37. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W & Witztum JL (1992): Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 339, 883-887.
38. Sarkkinen ES, Uusitupa MIJ, Nyyssönen K, Parviainen M, Penttilä I & Salonen JT (1993): Effects of two low-fat diets, high and low in polyunsaturated fatty acids, on plasma lipid peroxides and serum vitamin E levels in free-living hypercholesterolaemic men. Eur. J. Clin. Nutr. 47, 623-630.
39. Sauberlich HE (1994): Pharmacology of vitamin C. Annu. Rev. Nutr. 14, 371-391.
40. Sharma MK & Buettner GR (1993): Interaction of vitamin C and vitamin E during free radical stress in plasma: an ESR study. Free Rad. Biol. Med. 14, 649-653.
41. Stadtman ER (1991): Ascorbic acid and oxidative inactivation of proteins. Am. J. Clin. Nutr. 54, 1125S-1128S.
42. Uotila JT, Kirkkola A-L, Rorarius M, Tuimala RJ & Metsä-Ketelä T (1994): The total peroxyl radical-trapping ability of plasma and cerebrospinal fluid in normal and preeclamptic parturients. Free Rad. Biol. Med. 16, 581-590.
43. Vedie B, Myara MA, Pech JC, Maziere JC, Maziere C, Caprani A & Moatti N (1991): Fractionation of charge-modified low-density lipoproteins by fast protein liquid chromatography. J. Lipid. Res. 32, 1359-1369.
44. Vidgren M, Kumpusalo E, Silvasti M, Mykkänen M & Parviainen M (1992): Absorption of ascorbic acid from a film-coated tablet and from a new enteric-coated pellet preparation in subjects with inadequate plasma levels of ascorbic acid. Arzneim. Forsch. Drug Res. 42, 143-146.
45. Witztum JL (1994): The oxidation hypothesis of atherosclerosis. Lancet. 344, 793-795.
46. World Medical Assembly (1989). World medical association declaration of Helsinki.
47. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parathasarathy S, Carew TE, Butler S, Witztum JL & Steinberg D (1989): Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84, 1086-1095.